Unassociated Document


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):
 
March 24, 2011 (March 24, 2011)


 
HARRIS & HARRIS GROUP, INC.

(Exact name of registrant as specified in its charter)
         
New York
(State or other jurisdiction of
incorporation)
 
0-11576
(Commission File
Number)
 
13-3119827
(IRS Employer
Identification No.)


 
1450 Broadway
New York, New York 10018


 
(Address of principal executive offices and zip code)
 
(212) 582-0900


 
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

 
Item 8.01.    Other Events.

On March 24, 2011, Harris & Harris Group, Inc. (the “Company”) noted that Solazyme, Inc., today launched its AlgenistTM product in 800 Sephora stores in eight countries.  In addition, AlgenistTM will air on QVC at 10:00 p.m. EDT on Friday, March 25, 2011, during "Friday Night Beauty."  The Company is an investor in privately held Solazyme.  The Company’s press release is attached hereto as Exhibit 99.1.

Item 9.01.    Financial Statements and Exhibits.

 
(a)
Not applicable.
     
 
(b)
Not applicable.
     
 
(c)
Not applicable.
     
 
(d)
Exhibits.


 
Exhibit No.
Description
     
 
99.1
Press Release dated March 24, 2011



 
 

 


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Date:   March 24, 2011
HARRIS & HARRIS GROUP, INC.
     
     
     
 
By:
/s/ Douglas W. Jamison
   
Douglas W. Jamison
   
Chief Executive Officer


 
 

 

EXHIBIT INDEX

 
Exhibit No.
Description
     
 
99.1
Press Release dated March 24, 2011